Reported as an adaptor protein for RAS/MAPK, JAK/STAT, and PI3K pathways, CRKL led to the overexpression of apoptosis-inhibited gene BCL-2 in colon cancer (Lan et al., 2014). This evidence concerns the gene CRKL and malignant colon neoplasm.